Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
aTyr Pharma (ATYR) has received a new Buy rating, initiated by Leerink Partners analyst, Faisal Khurshid. Faisal Khurshid has given his Buy rating due to a combination of factors, most
...Read more
ATYR News on the Web
Yahoo Finance
Neutral
Zacks
Neutral
Zacks
Neutral
Yahoo Finance
Neutral
TipRanks News
Bullish
Yahoo Finance
Neutral
TipRanks News
Neutral
Yahoo Finance
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is ATYR’s Media Buzz Sentiment?
Currently, no data Available
What is ATYR’s weekly average amount of articles?
Currently, no data Available
What is ATYR’s News Sentiment?
50% of articles about ATYR were positive this week, compared to its sector average of 57%.